Latina Adolescent Depression Treatment Study

August 5, 2021 updated by: Duke University

Patient, Family, and Provider Perspectives on Latina Adolescents' Depression Treatment Engagement

Despite experiencing higher rates of depressive symptoms and similar rates of Major Depressive Disorder (MDD), Latina (female) adolescents in the U.S. are significantly less likely than their non-Latina White peers to receive treatment for MDD. The purpose of this study is to identify facilitators of and barriers to depression treatment engagement among Latina adolescents across patient-, family-, and healthcare provider-levels from the perspectives of these individuals. Latina adolescent-parent dyads and healthcare providers will be recruited from community and healthcare settings. Separate individual semi-structured interviews will be conducted with Latina adolescents (n=12) and their parents (n=12). Two focus groups will be conducted with primary care providers (n=6) and mental health providers (n=6) who frequently care for Latina youth. Qualitative content analysis will be used to analyze the transcripts to determine common themes in facilitators and barriers across stakeholder groups.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

25

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • North Carolina
      • Durham, North Carolina, United States, 27707
        • Lincoln Community Health Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 17 years (CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Latina adolescent young women experiencing depression and their parents will be recruited from community and integrated primary care settings. Healthcare providers will be recruited from an integrated primary care clinic.

Description

Adolescent Inclusion Criteria:

  • Ages 13-17
  • Self-identify as Hispanic/Latina
  • Be first generation (i.e. born outside the US) or second generation immigrants (i.e. one or both parents born outside the US)
  • Have been diagnosed with Major Depressive Disorder or Persistent Depressive Disorder/Dysthymia
  • Have been referred to psychotherapy or prescribed medication for depression

Adolescent Exclusion Criteria:

  • Currently experiencing acute psychological distress

Parent Inclusion Criteria

  • Parent of Latina adolescent experiencing depression

Parent Exclusion Criteria

  • Not fluent in English or Spanish

Healthcare Provider Inclusion Criteria

  • Self-identify as regularly providing clinical care to Latina adolescents with depression
  • Be in a role in which they can refer to or provide depression treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Latina adolescents and parents
Latina adolescent young women experiencing depression and their parents will be recruited from community and primary care settings for one-time individual interviews.
Healthcare providers
Primary care and mental health providers who commonly work with Latina adolescent patients will be recruited for focus groups from an integrated primary care clinic.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of barriers to depression treatment among Latina adolescents generated from patient interviews and provider focus groups
Time Frame: Baseline
Baseline
Number of facilitators of depression treatment among Latina adolescents generated from patient interviews and provider focus groups
Time Frame: Baseline
Baseline
Number of preferences for depression treatment generated from patient interviews and provider focus groups
Time Frame: Baseline
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Duke University

Collaborators

National Institute on Minority Health and Health Disparities (NIMHD)
National Institutes of Health (NIH)

Investigators

  • Principal Investigator: Rosa Gonzalez-Guarda, PhD, Duke University School of Nursing

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 1, 2019

Primary Completion (ACTUAL)

June 30, 2021

Study Completion (ACTUAL)

June 30, 2021

Study Registration Dates

First Submitted

November 13, 2019

First Submitted That Met QC Criteria

November 13, 2019

First Posted (ACTUAL)

November 15, 2019

Study Record Updates

Last Update Posted (ACTUAL)

August 6, 2021

Last Update Submitted That Met QC Criteria

August 5, 2021

Last Verified

July 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Pro00103001
  • U54MD012530 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe